Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cerulean Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cerulean Pharma Inc (CERU-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for CERU

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Apr 2016 ValuEngine, Inc. 11 $25.00

CERULEAN PHARMA INC (CERU=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Apr 2016 Pechala's Reports 2 $25.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharmaceutic...

15 Apr 2016 GlobalData 53 $300.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, Apr. 12, 2016 / 12:50PM ET

Edited Event Transcript of CERU.OQ conference call, Apr. 12, 2016 / 12:50PM ET New York, Apr 15, 2016 (Thomson StreetEv...

12 Apr 2016 Thomson Reuters StreetEvents 11 $75.00

Wright Investors Service Comprehensive Report for Cerulean Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

12 Apr 2016 Wright Reports 53 $75.00

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review

Cerulean Pharma, Inc. (CERU) - Financial Analysis Review Summary Cerulean Pharma, Inc. (Cerulean) formerly Tempo Pharmaceutic...

17 Mar 2016 GlobalData 54 $300.00

CERULEAN PHARMA - APPROACHING RELEASE OF PHASE II RENAL DATA

On 10 March Cerulean reassured the market by reporting in-line full-year 2015 results, reiterating an expected cash runway in...

16 Mar 2016 Edison Investment Research 3 $10.00

CERU.OQ - Event Transcript of Cerulean Pharma Inc conference call, Mar. 16, 2016 / 8:00AM ET

Edited Event Transcript of CERU.OQ conference call, Mar. 16, 2016 / 8:00AM ET Miami, Apr 2, 2016 (Thomson StreetEvents)...

16 Mar 2016 Thomson Reuters StreetEvents 7 $75.00